Determinants of access to experimental antiretroviral drugs in an Italian cohort of patients with HIV: a multilevel analysis

Determinants of access to experimental antiretroviral drugs in an Italian cohort of patients with HIV: a multilevel analysis

<p>Abstract</p> <p>Background</p> <p>Identification of the determinants of access to investigational drugs is important to promote equity and scientific validity in clinical research. We aimed to analyze factors associated with the use of experimental antiretrovirals in...

Full description

Bibliographic Details
Main Authors:	Girardi Enrico, Scognamiglio Paola, Angeletti Claudio, Gori Andrea, Buonfrate Dora, Arlotti Massimo, Mazzarello Giovanni, Castagna Antonella, Andreoni Massimo, d'Arminio Monforte Antonella, Antinori Andrea, Ippolito Giuseppe
Format:	Article
Language:	English
Published:	BMC 2012-02-01
Series:	BMC Health Services Research
Subjects:	antiretroviral therapy experimental drug HIV cohort study clinical trial expanded access program multilevel analysis
Online Access:	http://www.biomedcentral.com/1472-6963/12/38

Similar Items

Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study
by: Martina Spaziante, et al.
Published: (2021-07-01)

Pillars of long-term antiretroviral therapy success
by: Lucia Taramasso, et al.
Published: (2023-10-01)

Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options—the ICONA Foundation cohort study
by: Sergio Lo Caputo, et al.
Published: (2024-06-01)

Multilevel model on longitudinal data analysis in determinants of CD4 cell count among antiretroviral therapy attendant of HIV infected adults follow up in Gondar Teaching Referral Hospital, Gonder, Ethiopia
by: Kindu Kebede
Published: (2021-01-01)

Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort.
by: Antonella d'Arminio Monforte, et al.
Published: (2017-01-01)

Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV
by: Esther Merlini, et al.
Published: (2021-06-01)

Correction to: Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV
by: Esther Merlini, et al.
Published: (2021-06-01)

Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature
by: Camilla Tincati, et al.
Published: (2018-01-01)

Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice.
by: Silvia Costarelli, et al.
Published: (2016-01-01)

HIV-Infected Late Presenter Patients
by: Antonella D'Arminio Monforte, et al.
Published: (2012-01-01)

Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological Disorders
by: Maria Letizia Giancola, et al.
Published: (2012-01-01)

Role of In Vitro Stimulation with Lipopolysaccharide on T-Cell Activation in HIV-Infected Antiretroviral-Treated Patients
by: Camilla Tincati, et al.
Published: (2012-01-01)

Safety of antiretroviral drugs
by: Anđelković Milena, et al.
Published: (2016-01-01)

Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection–Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study
by: Antonio Muscatello, et al.
Published: (2020-02-01)

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
by: Cristina Mussini, et al.
Published: (2015-01-01)

Multilevel determinants of antiretroviral therapy initiation and retention in the test-and-treat era of Nepal: a qualitative study
by: Archana Shrestha, et al.
Published: (2024-08-01)

Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy.
by: Esther Merlini, et al.
Published: (2011-01-01)

Antiretroviral stewardship in a tertiary academic hospital: The need for a clinical pharmacist
by: Elmien Bronkhorst, et al.
Published: (2023-08-01)

Start and succeed in multilevel marketing /
by: Kishel, Gregory F., 1946-, et al.
Published: (1999)

Expanding Treatment Opportunities: Reviewing the Current State of Injectable Antiretrovirals for Treatment of HIV
by: Amanda Binkley, et al.
Published: (2024-10-01)

Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients.
by: Nicola Gianotti, et al.
Published: (2017-01-01)

High incidence of adverse reactions to initial antiretroviral therapy in Brazil
by: C.A. Menezes de Pádua, et al.
Published: (2006-04-01)

Guidelines for antiretroviral therapy in adults
by: G Meintjes, et al.
Published: (2012-08-01)

The SAGE handbook of multilevel modeling /
by: Scott, Marc A., et al.
Published: (2013)

Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort.
by: Antonella Cingolani, et al.
Published: (2014-01-01)

A Cascaded Multilevel Inverter Based on a New Basic Unit
by: Roya Naderi, et al.
Published: (2023-06-01)

A Hybrid Modular Multilevel Converter with Partial Embedded Energy Storage
by: Georgios Konstantinou, et al.
Published: (2016-11-01)

Risk-factors for non-adherence to antiretroviral therapy Fatores preditivos de não-adesão à terapia antiretroviral
by: Márcia Cristina Fraga Silva, et al.
Published: (2009-06-01)

Application of multilevel modeling in educational data /
by: Koh Sing Yee, 1990- author, et al.
Published: (2014)

Factors affecting the happiness level in Southeast Asia countries with a multilevel approach
by: OKTIVA RAHMAWATI DHEWI, et al.
Published: (2024-02-01)

Factors influencing adherence to antiretroviral therapy among young adults in Limpopo province
by: Victoria Mashele, et al.
Published: (2024-08-01)

Investigating the effect of selected antiretroviral therapies on serum testosterone and testicular microstructure of Wistar rats
by: Edagha IA, et al.
Published: (2021-07-01)

Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort
by: Chua Arlene C, et al.
Published: (2012-06-01)

One size doesn’t fit all: Tailoring adult antiretroviral treatment
by: Nathan Geffen, et al.
Published: (2014-09-01)

Multilevel modeling /
by: Luke, Douglas A., author.
Published: (2020)

Multilevel modelling /
by: Skrondal, Anders, et al.
Published: (2010)

Experimental Investigation on the Performances of a Multilevel Inverter Using a Field Programmable Gate Array-Based Control System
by: Guido Ala, et al.
Published: (2019-03-01)

Diagnosis, antiretroviral therapy, and emergence of resistance to antiretroviral agents in HIV-2 infection: a review
by: Maia Hightower, et al.

Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium
by: Julie Jesson, et al.
Published: (2020-05-01)

Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemic
by: Rebecka Papaioannu Borjesson, et al.
Published: (2023-09-01)